Revised key messages for hormone replacement therapy from the New Zealand Guidelines Group.

about

Revised key messages for hormone replacement therapy from the New Zealand Guidelines Group.

Item

http://www.wikidata.org/entity/Q39385861

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Revised key messages for hormo ...... New Zealand Guidelines Group.

@en

Revised key messages for hormo ...... New Zealand Guidelines Group.

@nl

type

Item

label

Revised key messages for hormo ...... New Zealand Guidelines Group.

@en

Revised key messages for hormo ...... New Zealand Guidelines Group.

@nl

prefLabel

Revised key messages for hormo ...... New Zealand Guidelines Group.

@en

Revised key messages for hormo ...... New Zealand Guidelines Group.

@nl

P1476

Revised key messages for hormo ...... New Zealand Guidelines Group.

@en

P2093

Anne Lethaby

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial.

Postmenopausal hormone replacement therapy: scientific review.

AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

Evidence from randomised trials on the long-term effects of hormone replacement therapy.

Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease.

The randomized world is not without its imperfections: reflections on the Women's Health Initiative Study.

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial.

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study.

Effects of estrogen plus progestin on health-related quality of life.

P304

273-279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.0004-8666.2003.00090.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Helen Roberts

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14714711

http://www.w3.org/2001/XMLSchema#string

P921

New Zealand